FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and pharmacology and concerns application of carbamazepine derivatives of formula 
(1) for treating excitation in patients, method of excitation treatment, pharmacologic composition for excitation treatment, combination of formula (1) compound with nootropic agent for excitation treatment, application of combination for preparation of medication for treating excitation and industrial packing.
EFFECT: invention ensures high efficiency of treatment
16 cl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION WHICH CONTAINS VIRUS-LIKE PARTICLE (VLP) AND AMYLOID-BETA PEPTIDE | 2005 |
|
RU2415677C2 |
| COMPOSITION CONTAINING AMYLOIDAL PEPTIDE Aβ-1-6 ATTACHED TO VIRUS-LIKE PARTICLE AND ADJUVANT | 2011 |
|
RU2603486C2 |
| APPLICATION OF SPHINGOSINE-1-PHOSPHATE (SIP) RECEPTOR AGONISTS FOR TREATMENT OF DEGENERATIVE BRAIN DISEASES | 2004 |
|
RU2379030C2 |
| COMPOSITIONS, CONTAINING CHOLINESTERASE INHIBITOR FOR TREATING COGNITIVE DISORDERS | 2010 |
|
RU2607946C2 |
| APPLICATION OF 10-HYDROXY-10,11-DIHYDROCARBAMAZEPINE DERIVATIVES FOR TREATMENT OF AFFECTIVE DISORDERS | 2004 |
|
RU2367440C2 |
| QUINAZOLINE DERIVATIVES | 2005 |
|
RU2414468C2 |
| APPLICATION OF DERIVATIVES OF SICCINE ACID ETHERS FOR TREATMENT OF DEMENTIA | 2003 |
|
RU2334524C2 |
| APPLICATION OF CHOLINESTERASE INHIBITORS FOR TREATMENT OF VASCULAR DEPRESSION | 2005 |
|
RU2397762C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
| METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
